These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33716501)

  • 1. Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids.
    Huang YJ; Kao S; Kao LT; Chian CF; Chung CH; Chien WC; Wang KY
    Int J Chron Obstruct Pulmon Dis; 2021; 16():591-602. PubMed ID: 33716501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
    Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.
    Huang CC; Chan WL; Chen YC; Chen TJ; Chou KT; Lin SJ; Chen JW; Leu HB
    Clin Ther; 2011 Oct; 33(10):1365-70. PubMed ID: 21962452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.
    Damkjær M; Håkansson K; Kallemose T; Ulrik CS; Godtfredsen N
    Int J Chron Obstruct Pulmon Dis; 2021; 16():579-589. PubMed ID: 33707941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use and risk of COPD exacerbation requiring hospitalization.
    Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
    Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Use of Antihyperlipidemic Agents and Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study.
    Lei YF; Lin HC; Lin HL; Uang YS; Cheng HW; Wang LH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2573-2581. PubMed ID: 33116474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink.
    Smith MC; Ashdown HF; Sheppard JP; Butler CC; Bankhead C
    BMJ Open; 2021 Dec; 11(12):e050757. PubMed ID: 34876426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
    Frantzi N; Nguyen XP; Herr C; Alter P; Söhler S; Soriano D; Watz H; Waschki B; Trinkmann F; Eichenlaub M; Trudzinski FC; Michels-Zetsche JD; Omlor A; Seiler F; Moneke I; Biertz F; Rohde G; Stolz D; Welte T; Kauczor HU; Kahnert K; Jörres RA; Vogelmeier CF; Bals R; Fähndrich S;
    Respir Res; 2024 May; 25(1):207. PubMed ID: 38750572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort Study.
    Sun SH; Chang CH; Zhan ZW; Chang WH; Chen YA; Dong YH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2721-2733. PubMed ID: 34621122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
    Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use is associated with reduced mortality in COPD.
    Søyseth V; Brekke PH; Smith P; Omland T
    Eur Respir J; 2007 Feb; 29(2):279-83. PubMed ID: 17050558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies.
    Howard ML; Vincent AH
    Pharmacotherapy; 2016 May; 36(5):536-47. PubMed ID: 26990316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
    Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
    Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research.
    Cao C; Wu Y; Xu Z; Lv D; Zhang C; Lai T; Li W; Shen H
    Sci Rep; 2015 Nov; 5():16461. PubMed ID: 26553965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary disease.
    Yayan J
    Int J Med Sci; 2015; 12(3):280-7. PubMed ID: 25798054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.
    Slade D; Ray R; Moretz C; Germain G; Laliberté F; Shen Q; Duh MS; Mahendran M; Hahn B
    BMC Pulm Med; 2021 Jul; 21(1):253. PubMed ID: 34332555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and outcome after hospitalization for COPD exacerbation: a prospective study.
    Bartziokas K; Papaioannou AI; Minas M; Kostikas K; Banya W; Daniil ZD; Haniotou A; Gourgoulianis KI
    Pulm Pharmacol Ther; 2011 Oct; 24(5):625-31. PubMed ID: 21729761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.